pemigatinib
incyte,specialised therapeutics
super proud of my colleague for presenting the final analysis of the practice changing fight-202 trial for pts with fgfr2 altered #cholangiocarcinoma at #wcgic2022 #livertwitter 
Clinician/Scientist with a passion for hepato-oncology and basic science. Member of the EASL YI Task Force, EASL social media ambassador #LiverTwitter